Growth Hormone Deficiency (GHD): Clinical Trials

11 trials for Growth Hormone Deficiency (GHD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 2 not yet recruiting, 1 terminated. 6 Phase 3, 3 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 36Not yet recruiting 2, Recruiting 2, Terminated 1, Unknown 1
Phase 23Completed 2, Not yet recruiting 1
Not applicable1Recruiting 1

Follow Growth Hormone Deficiency (GHD): new trials by email Literature Review of Growth Hormone Deficiency (GHD) trials Research Report on Growth Hormone Deficiency (GHD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency
LUM-201 - Growth Hormone Deficiency (GHD)
Phase 3Not yet recruitingLumos Pharma1502027-02-012026-07-08
GB06 Phase III Trial for Pediatric Growth Hormone Deficiency
GB06, Norditropin®FlexProTM - Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children
Phase 3RecruitingKexing Biopharm Co., Ltd.1922026-06-062026-06-10
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
LUM-201, Matched Placebo (Capsules) - Growth Hormone Deficiency (GHD)
Phase 3RecruitingLumos Pharma1502026-05-202026-10-19
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
REMS - Osteogenesis Imperfecta, Osteoporosis
Not applicableRecruitingMeyer Children's Hospital IRCCS1002025-12-042026-02-17
Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
GB08, Norditropin NordiFlex - Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD)
Phase 2 / Phase 3Not yet recruitingShenzhen Kexing Pharmaceutical Co., Ltd.2682025-08-312025-08-22
Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology
ACDP® and growth hormone treatment - Growth Hormone Deficiency (GHD)
CompletedLuis Fernandez Luque402025-05-192025-12-01
Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma
Craniopharyngioma, Growth Hormone Deficiency (GHD)
CompletedWest China Hospital5002023-12-012026-01-15
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
MOD-4023 - Growth Hormone Deficiency (GHD)
Phase 2CompletedOPKO Health, Inc.482014-02-012025-04-09
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
ACP-001, Human Growth Hormone - Growth Hormone Deficiency (GHD)
Phase 2CompletedAscendis Pharma A/S532013-07-012026-07-08
Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
Saizen® - Growth Hormone Deficiency (GHD)
Phase 3TerminatedEMD Serono592010-10-012013-08-07
Treatment of Children With Insufficient Secretion of Growth Hormone
growth hormone (somatropin) - Growth Hormone Deficiency (GHD)
Phase 3UnknownLG Life Sciences1442005-09-012010-03-17

Narrower conditions

Dwarfism, Pituitary (11)  ·  Bone Diseases, Metabolic (1)  ·  Craniopharyngioma (1)  ·  Cushing Syndrome (1)  ·  Malnutrition (1)  ·  Neoplasms (1)  ·  Obesity (1)  ·  Osteogenesis Imperfecta (1)  ·  Osteoporosis (1)  ·  Overweight (1)

Broader conditions

Bone Diseases (11)  ·  Bone Diseases, Developmental (11)  ·  Bone Diseases, Endocrine (11)  ·  Brain Diseases (11)  ·  Central Nervous System Diseases (11)  ·  Dwarfism (11)  ·  Endocrine System Diseases (11)  ·  Hypopituitarism (11)  ·  Hypothalamic Diseases (11)  ·  Musculoskeletal Diseases (11)  ·  Nervous System Diseases (11)  ·  Pituitary Diseases (11)  ·  Adrenal Gland Diseases (1)  ·  Adrenocortical Hyperfunction (1)  ·  Body Weight (1)

Interventions

Human Growth Hormone (3)  ·  Growth Hormone (2)  ·  2-amino-3-cyano-6-methyl-5-(3,4-dimethoxyphenyl)pyridine (1)  ·  Capsules (1)  ·  MOD-4023 (1)

Sponsors

Lumos Pharma (2)  ·  Ascendis Pharma A/S (1)  ·  EMD Serono (1)  ·  Kexing Biopharm Co., Ltd. (1)  ·  LG Life Sciences (1)  ·  Luis Fernandez Luque (1)  ·  Meyer Children's Hospital IRCCS (1)  ·  OPKO Health, Inc. (1)  ·  Shenzhen Kexing Pharmaceutical Co., Ltd. (1)  ·  West China Hospital (1)

Countries

United States (4)  ·  China (3)  ·  Belarus (2)  ·  Greece (2)  ·  Hungary (2)  ·  Russia (2)  ·  Ukraine (2)  ·  Argentina (1)  ·  Australia (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Czechia (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)

Top investigators

Junfen Fu (1)  ·  Yijia Zhang (1)  ·  Zvi Zadik, MD (1)

Results publications

PMID 24170106, PMID 28201598